Lilly on Thursday reported fourth-quarter revenue of $13.53 billion, a steep 45% increase over the sum the Indianapolis-based drugmaker generated during the same period in 2023.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback